Welcome back to the CPHI Exhibitor Spotlight!

We’re continuing our journey through the standout companies heading to CPHI Americas 2025, and next up is Adare - a global leader known for turning complex formulation challenges into innovative, patient-centric solutions.

What exciting innovations or products will you be showcasing at CPHI Americas?

3D Screen Printing

In collaboration with Laxxon Medical, Adare Pharma Solutions is now providing 3D screen printing capabilities to our customers. This technology represents a transformative opportunity for drug development by enabling complex drug delivery systems that simply can't be achieved via traditional methods.

3D screen printing is a scalable, additive manufacturing process that facilitates precise, layer-by-layer construction of drug formulations. This allows integration of immediate, extended, delayed, and sequential release mechanisms within a single tablet. We can also use the technology to easily incorporate multiple APIs with distinct pharmacokinetic profiles into one dosage form, offering unprecedented therapeutic flexibility.

As personalized medicine and patient-centric therapies become the norm, we’re going to see 3D screen printing play a major role in helping sponsors bring smarter, more targeted products to market.

MMTS™ Minitabs

We'll also be showcasing our MMTS™ Minitabs technology, which combines the simplicity and high drug-loading capacity of tablets with the flexibility to deliver a wide range of release profiles tailored to both patient needs and drug characteristics.

This multiparticulate dosage form enables the delivery of dozens or even hundreds of cylindrical Minitabs (1.0–2.0 mm) in convenient formats such as capsules, sachets, or sprinkles. Each Minitab contains the active pharmaceutical ingredient (API) and excipients enclosed within specialized polymer coatings that precisely control drug dissolution and diffusion.

Supported by Adare’s robust commercial-scale manufacturing capabilities and validated clinical performance, MMTS Minitabs can help overcome key formulation challenges, including dose precision, patient compliance, and therapeutic efficacy.

Why did you choose to exhibit at this event?

We're delighted to exhibit at CPHI Americas because it’s a premier pharmaceutical industry event that's hosted in our own backyard: Philadelphia, a vital and growing hub for life sciences. As a global CDMO headquartered in Philly, we’re proud to support and engage with the industry here.

CPHI Americas, like its sister show CPHI Worldwide, brings together pharma professionals, innovators, and businesses of all sizes to connect, collaborate, and explore the future of pharmaceutical development.

Unlike smaller and more specialized events, CPHI Americas offers access to representatives from the entire pharmaceutical supply chain under one roof. That’s especially valuable for a company like Adare, which provides end-to-end services from development to commercial manufacturing that allow us to seamlessly scale and commercialize complex products across our global and regional manufacturing capabilities.

Who would you like to meet at the event?

We’d love to meet pharmaceutical companies looking for a trusted CDMO partner to support them from early development through commercial manufacturing and packaging.

We’re especially eager to connect with teams developing small molecule oral dosage forms who are seeking expertise in customized release profiles, taste masking, or patient-centric dosing.

We’re also interested in speaking with companies in need of a globally integrated partner with the capacity and experience to bring complex formulations to market efficiently. With seven facilities across the US and Europe and over 65 products developed and manufactured for our customers, Adare has extensive experience executing smooth, efficient tech transfers, both for products in development and for commercialized therapies needing a new manufacturing partner. Whether customers are launching a new product or optimizing supply of an established product, we can provide the technical depth, regulatory expertise, and operational flexibility to meet evolving needs and ensure long-term success.

Finally, we’d like to meet with companies who are looking for a development and manufacturing partner with a strong global and regional presence. With facilities in the world’s two largest pharmaceutical markets, the U.S. and Europe, Adare offers regional access, supply chain flexibility, and the operational resilience needed to keep projects moving forward.